Third, the blood concentration of rosiglitazone derived from oral administration while used for the treatment of hyperglycemia in humans does not guarantee a delivery of sufficient rosiglitazone to the colon for the activation of PPARγ locally. Here, PPARG is linked to Hyperglycemia.